Cancer

Kanazawa University research: Scientists develop a new method to measure cellular energy in real time

KANAZAWA, Japan, Nov. 20, 2025 /PRNewswire/ -- Researchers at the Nano Life Science Institute (WPI-NanoLSI), Kanazawa University, have developed a…

1 month ago

Onco-Innovations Advances Optimization and Scale-Up of Its PNKP Inhibitor Technology with Dalton Pharma Services to Support Future Phase 1 Clinical Studies

VANCOUVER, BC / ACCESS Newswire / November 20, 2025 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN:A3EKSZ) ("Onco" or the "Company") is…

1 month ago

MyOme Launches First Integrated Polygenic Risk Score for Prostate Cancer to Advance Early Detection and Personalized Prevention

New whole-genome test uncovers hidden genetic risk beyond traditional screening, empowering earlier and more precise care for millions of men.…

1 month ago

Voio Emerges From Stealth to Build Frontier AI for Healthcare

Voio team’s initial open-source release, Pillar-0, is the world’s most accurate AI model for radiology and builds on the success…

1 month ago

Voio Emerges From Stealth to Build Frontier AI for Healthcare

Voio team’s initial open-source release, Pillar-0, is the world’s most accurate AI model for radiology and builds on the success…

1 month ago

St. Baldrick’s Foundation Awards Nearly $1.2 Million in Grants, Advancing Research and Hope for Kids with Cancer

Los Angeles, California--(Newsfile Corp. - November 20, 2025) - The St. Baldrick's Foundation, the largest charity funder of childhood cancer…

1 month ago

ViVac Appoints Keren Leshem as Chief Executive Officer, Strengthening Leadership to Advance RNA-Lipid Nanoparticle Immunotherapy Platform

JERUSALEM, Nov. 20, 2025 /PRNewswire/ -- ViVac Pharma Ltd., a pioneering synthetic biology company advancing RNA–Lipid Nanoparticle (LNP) immunotherapies, announces the…

1 month ago

Oxford-Harrington Rare Disease Centre Announces 2025 Scholars Advancing Promising Treatments

Ten scientists selected for second annual award to pursue innovations in gene, RNA, small molecule and cell therapies to treat…

1 month ago

Altamira Therapeutics Announces Certification of Bentrio Nasal Spray under Medical Device Regulation

Conformity with stringent new EU regulations for medical devices confirmedAllows for commercialization of Bentrio in EU member states; facilitates regulatory…

1 month ago

Altamira Therapeutics Announces Certification of Bentrio Nasal Spray under Medical Device Regulation

Conformity with stringent new EU regulations for medical devices confirmedAllows for commercialization of Bentrio in EU member states; facilitates regulatory…

1 month ago